Hudson Bay Capital Management LP Larimar Therapeutics, Inc. Transaction History
Hudson Bay Capital Management LP
- $25.3 Billion
- Q3 2025
A detailed history of Hudson Bay Capital Management LP transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 498,200 shares of LRMR stock, worth $1.68 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
498,200
Previous 498,000
0.04%
Holding current value
$1.68 Million
Previous $1.44 Million
11.81%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding LRMR
# of Institutions
154Shares Held
89MCall Options Held
6.44MPut Options Held
622K-
Deerfield Management Company, L.P. (Series C) New York, NY30.6MShares$103 Million1.84% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$20.4 Million0.34% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.85MShares$19.8 Million8.2% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.9MShares$16.6 Million0.01% of portfolio
-
Opaleye Management Inc. Boston, MA3.72MShares$12.6 Million2.0% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $146M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...